930780

AstraZeneca Pharmaceuticals LP — FEI 2518137

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 19, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wilmington, DE (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)